Funder: European Commission
Due Dates: February 12, 2026 (Pre-proposal) | April 7, 2026 (Next pre-proposal collection) | July 8, 2026 (Full proposal)
Funding Amounts: €31,186,922 total; typical consortia of 4–6 (up to 8) partners; project budgets and durations subject to national rules.
Summary: Supports international collaborative research to resolve unsolved cases in rare genetic and non-genetic diseases, emphasizing innovation, patient engagement, and transnational data harmonization.
Key Information: Two-stage application (pre-proposal/full); strong patient partner involvement required; strict consortium composition rules.